Bemotrizinol is a sunscreen active ingredient that helps protect your skin from ultraviolet A (UVA) and ultraviolet B (UVB) rays. Parsol Shield is expected to be the first sunscreen available with this ingredient. The FDA… Read more
Tzield (teplizumab-mzwv) is a prescription immune therapy that can help delay the progression of type 1 diabetes (T1D). The FDA has approved Tzield for slowing the decline of natural insulin production in children aged 8-17… Read more
Truqap (capivasertib) is an oral targeted cancer medicine. The FDA has now approved it to be used together with abiraterone and prednisone for a specific type of advanced prostate cancer. It applies to adults whose… Read more
The FDA has approved a new treatment called Tregzi. It uses a special kind of immune cell called a regulatory T cell, or Treg. Tregzi is for adults with certain high-risk blood cancers who are… Read more
Trutakna (atacicept) is an injection that is approved for adults with a kidney disease called primary immunoglobulin A nephropathy, or IgAN. It is a type of medicine known as an immunomodulator. People with IgAN make… Read more
The FDA approved two options of medicine for adults with a certain type of bladder cancer. This cancer is called muscle-invasive bladder cancer. It means the cancer has grown deep into the main muscle wall… Read more
The FDA has approved Sarclisa Escena (isatuximab-irfc) for adults with a type of bone marrow cancer called multiple myeloma. This medicine is used along with other standard cancer drugs in people who are newly diagnosed… Read more
Wilate is an injectable medicine used to treat and control bleeding in people with von Willebrand disease (VWD), an inherited bleeding disorder. The medicine is made from human plasma. It contains two important proteins that… Read more
Leqembi (lecanemab) is a prescription medicine for Alzheimer’s disease. This disease is a brain disorder that slowly destroys memory and thinking skills. Over time, it makes it hard to do simple daily tasks. Alzheimer’s disease… Read more
The FDA has approved a new medicine called Revtorpyk (gedatolisib) to treat adults with a certain form of advanced breast cancer that is hormone receptor-positive (HR-positive) and HER2-negative. These terms describe specific proteins found on… Read more